Released on 20th January 2021 by London NHS, London COVID-19 dexamethasone and hyperglycaemia: diabetes de-escalation guidance is now available for download.
Privacy Policy | Website Terms and Conditions
Address for correspondence: ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS
Telephone: 01675 477602 Email: info@abcd.care
ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd
ABCD Corporate Pharma Sponsors; Gold: Astra Zeneca, Boehringer Ingelheim & Eli Lilly & Co Alliance, Lilly, Sanofi.
ABCD Corporate Pump & Device Supporters, Gold: Abbott Laboratories Ltd, Dexcom, GlucoRx, Insulet International Ltd; Silver: Medtronic Ltd, Medtrum Ltd; Bronze: Air Liquide Healthcare Ltd, CamDiab, Roche Diabetes Care, Ypsomed.
